We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Colin Kellaher Shares of Travere Therapeutics tumbled nearly 35% and hit a new 52-week low Tuesday after the biopharmaceutical company said a pivotal Phase 3 study of its kidney drug Filspari...
By Chris Wack Arcturus Therapeutics Holdings Inc. shares were up 31% to $24.03 after it entered into a strategic collaboration with CSL Seqirus for the research, development, manufacture and...
By Josh Beckerman Arcturus Therapeutics Holdings Inc. shares rose 26% to $23.10 after hours as the company announced a vaccine collaboration with CSL Ltd.'s CSL Seqirus. Arcturus will receive...
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220307005938/en/ AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL...
By Joshua Kirby Shares in Vifor Pharma AG rose sharply in opening trade Tuesday after receiving an offer from Australia's CSL Ltd. that values the company at $11.7 billion. At 0812 GMT...
By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it has made a US$11.7 billion all-cash offer for Switzerland's Vifor Pharma Ltd. as it aims to add renal-disease...
By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. has made an all-cash offer for Vifor Pharma Ltd. that values the Swiss pharmaceutical developer's equity at US$11.7...
By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it had made an all-cash offer for Vifor Pharma Ltd. that values the Swiss pharmaceutical developer's equity at...
By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it is in talks with Vifor Pharma Ltd. over a potential acquisition of the Switzerland-based pharmaceutical company. CSL...
By Mike Cherney SYDNEY -- A Covid-19 vaccine candidate in Australia has been scrapped because recipients returned false positives on certain HIV tests, underscoring the difficulties scientists...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -11.3 | -3.95935529082 | 285.4 | 308.01 | 271.02 | 495262 | 282.78385111 | DE |
4 | -30.38 | -9.97766684183 | 304.48 | 310 | 271.02 | 482453 | 288.03850738 | DE |
12 | -35.18 | -11.374806001 | 309.28 | 360.01 | 160 | 539108 | 294.07209666 | DE |
26 | -6.43 | -2.29208997255 | 280.53 | 380.01 | 0.11 | 633311 | 295.34341117 | DE |
52 | 15.86 | 6.14157372986 | 258.24 | 380.01 | 0.11 | 645800 | 288.29453214 | DE |
156 | -36.9 | -11.8649517685 | 311 | 380.01 | 0.11 | 744993 | 280.44562223 | DE |
260 | -0.75 | -0.272876114244 | 274.85 | 400 | 0.11 | 785728 | 285.07587715 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions